The Beyond Celiac Coalition
Since 2003, Beyond Celiac has been the leading patient advocacy and research-driven celiac disease organization working to drive diagnosis, advance research and accelerate the discovery of new treatments and a cure.
To achieve these goals faster, Beyond Celiac has formed a coalition of members from academia, key opinion leaders, government agencies, and pharmaceutical, biotech, and diagnostic companies. Together, we identify and address significant roadblocks to the diagnosis and treatment of celiac disease.
Coalition Objectives
- Identify significant roadblocks to the diagnosis and treatment of celiac disease.
- Address major patient barriers to accelerate clinical trials for celiac disease.
To that end, the goals of the coalition are as follows:
- Increase and accelerate patient enrollment
- Address the value of histology in clinical trial development
- Standardize the gluten challenge
- Expand the clinical trials network
- Validate prognostic and diagnostic biomarkers
- Develop best practices to increase clinical trial diversity
- Increase pediatric opportunities
- Better utilize real-world evidence
- Provide enhanced testing for non-celiac gluten sensitivity
Current Priorities and Progress
The Coalition’s unique composition and pre-competitive nature lends itself well to hosting a monthly meeting among stakeholders committed to accelerating a cure for celiac disease. Primary objectives for 2026-2027 are:
- 2026 Burden of Disease Survey: Distributing, analyzing, and sharing results to drive discussions around the critical need for treatments beyond the gluten-free diet.
- Clinical Trial Awareness: Promoting education to boost enrollment and accelerate research.
- Drug Development Priorities: Advancing continuous work on celiac disease symptoms, histology, biomarkers, and endpoints.
FDA Collaboration & Impact
The Beyond Celiac Coalition has engaged in two collaborative meetings with the FDA, patients and other stakeholders to advance patient-centric solutions. Milestones include:
- February 2026: Discussed strategies for designing rigorous, effective celiac clinical trials for pediatric populations.
- May 2024: Focused on approaches to make adult therapeutic trials more patient-centric while maintaining strict scientific rigor.
Membership
There are various membership tiers in our Coalition structure, each offering varying benefits. The Beyond Celiac Coalition is operated and funded by annual membership dues, with projects funded from supplemental funds industry members provide. Participation in individual projects is offered to all members. Individual project costs, principally event venue, external support and/or travel for academic members are agreed upon and shared equally among all industry member organizations participating in those projects.
Member Benefits
- Play a role in shaping best practices and accelerating celiac disease clinical trials
- Gain knowledge and insights that will help advance business decisions
- Leverage resources in a pre-competitive environment
- Gain access to shared data
- Contribute to celiac disease science and the expansion of the clinical trials network
- Have the opportunity to work collaboratively, both in person and remotely, with other members of the Beyond Celiac Coalition
- Receive frequent communications on the latest science/trends
Learn More and Join
To learn more about membership opportunities, contact our director of corporate partnerships Deanne Field at [email protected]